Epidermal growth factor receptor immunohistochemistry-Reference-Cited by-同舟云学术

Epidermal growth factor receptor immunohistochemistry

Published:2008 Issue:5 Volume:112 Page:1114-1121
ISSN:0008-543X
Container-title:Cancer
language:en
Short-container-title:Cancer

Author:

Hirsch Fred R.,Dziadziuszko Rafal,Thatcher Nick,Mann Helen,Watkins Claire,Parums Dinah V.,Speake Georgina,Holloway Brian,Bunn Paul A.,Franklin Wilbur A.

Publisher

Wiley

Subject

Cancer Research,Oncology

Reference31 articles.

1. Multi-Institutional Randomized Phase II Trial of Gefitinib for Previously Treated Patients With Advanced Non–Small-Cell Lung Cancer

2. Efficacy of Gefitinib, an Inhibitor of the Epidermal Growth Factor Receptor Tyrosine Kinase, in Symptomatic Patients With Non–Small Cell Lung Cancer

3. Phase II Clinical Trial Data with the Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor Erlotinib (OSI-774) in Non–Small-Cell Lung Cancer

4. Gefitinib plus best supportive care in previously treated patients with refractory advanced non-small-cell lung cancer: results from a randomised, placebo-controlled, multicentre study (Iressa Survival Evaluation in Lung Cancer)

5. Molecular Predictors of Outcome With Gefitinib in a Phase III Placebo-Controlled Study in Advanced Non–Small-Cell Lung Cancer

Cited by 67 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Emerging targeted therapies in oral oncology: Focus on EGFR inhibition;Oral Oncology Reports;2024-09

2. To Investigate Growth Factor Receptor Targets and Generate Cancer Targeting Inhibitors;Current Topics in Medicinal Chemistry;2023-12

3. Impact of Menopausal Status on Imaging Findings of Patients With Triple-Negative Breast Cancer;J BREAST IMAGING;2022

4. Structural Insight and Development of EGFR Tyrosine Kinase Inhibitors;Molecules;2022-01-26

5. MicroRNA‑27b‑3p inhibits the proliferation and invasion of cutaneous squamous cell carcinoma by targeting EGFR and MMP‑13;Oncology Letters;2021-08-10